Inlyta

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2017
012320122017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Tyrosine kinase inhibitors (TKIs) are oral chemotherapy drugs used primarily to treat leukemias, renal cell carcinomas… (More)
Is this relevant?
Review
2015
Review
2015
Axitinib is a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 1 (VEGFR-1), VEGFR-2, and VEGFR-3. Based… (More)
Is this relevant?
Review
2013
Review
2013
In the United States, drugs and medical devices are regulated by the US Food and Drug Administration (FDA). A drug must undergo… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
Review
2013
Review
2013
  • Nature Biotechnology
  • 2013
1 2012 was not a banner year for sales of newly launched biotech drugs. Revenues of Regeneron’s decoy receptor Zaltrap were… (More)
Is this relevant?
Review
2012
Review
2012
The 21st century has seen an explosion in the development of agents for renal-cell carcinoma (RCC), a malignancy previously… (More)
Is this relevant?
Review
2012
Review
2012
The landscape of treatment for metastatic renal cell carcinoma (mRCC) continues to evolve. Although several new drugs have been… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
2012
2012
  • The Medical letter on drugs and therapeutics
  • 2012
 
Is this relevant?